Scientists have unearthed surprising details about how our bodies handle insulin—the hormone that plays a crucial role in ...

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Smart Insulin Pens Market were the three major steps undertaken to create and analyze ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless non-patented drugmakers such as Biocon Ltd. step in to plug the gap in a $34 ...

Q2 2025 Earnings Call Transcript May 9, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.7, expectations were $0.66. Operator: Welcome, ladies and gentlemen, to Embecta Corp.’s ...

Some companies are already taking steps to provide lower-cost products. Earlier this month, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in ...

South Africa's regulator has also been called on by advocacy groups to examine whether Novo's focus on manufacturing injectable weight-loss drugs has contributed to insulin pen supply problems. Step ...

Civica did not participate in the hearing but previously told CalMatters that the company has started manufacturing insulin, which is one of the steps that must be completed ... $55 for a box of five ...

Patients administer the prefilled pen via subcutaneous injection ... The approval of Merilog represents a potentially significant step toward lowering insulin costs in the US.